BioCeuticals MenoPlus 8-PN 60t

Description

MenoPlus 8-PN® is a unique herbal formula containing herbs and nutrients including Lifenol® 8-PN, a phytoestrogen clinically demonstrated to reduce the incidence of hot flushes associated with menopause. The formula now features zizyphus and lavender oil, as well as multiple standardised herbal ingredients. MenoPlus 8-PN® includes sage used in traditional Western herbal medicine (WHM) systems to relieve night sweats associated with menopause, hops and lavender traditionally used in WHM to assist with sleep, vitamin C to support nervous system function and vitamin D to support bone health.

Features:

• Features clinically-trialled Lifenol® to relieve hot flushes associated with menopause.
• Contains a broad range of herbs including rehmannia, zizyphus, and standardised hops, lavender, sage and shatavari.
• Hops and lavender are traditionally used in WHM to assist with sleep.
• Vitamin C supports nervous system function and helps to relieve tiredness, fatigue and feelings of weakness.
• Vitamin D helps to support bone health.
• Enteric coated capsule for improved palatability.
  

 

Each tablet contains:
Herbal extracts standardised equiv. to dry:
Humulus lupulus (hops) flower - Lifenol®	2g
equiv. to 8-prenylnaringenin	75mcg
Salvia officinalis (sage) leaf	1.5g
equiv. to thujone	3mcg
Asparagus racemosus (shatavari) root	1.1g
equiv. to shatavarin	2.8mg
Herbal extracts equiv. to dry:
Ziziphus jujuba var. spinosa (zizyphus) seed	3g
Rehmannia glutinosa (rehmannia) root	1g
Essential oil:
Lavandula angustifolia (lavender) oil	40mg
equiv. to linalool	13mg
equiv. to linalyl acetate	14.4mg
Nutrients:
Ascorbic acid (vitamin C)	100mg
Colecalciferol	12.5mcg
equiv. vitamin D3	500IU

 

No added dairy, gluten, shellfish, soy protein.

Vegetarian friendly.

• If symptoms persist consult your healthcare practitioner.
• Vitamin supplements should not replace a balanced diet.
• Always read the label. Use only as directed.

Prescribing Information:

• This product is not recommended for use in pregnancy and lactation.
• Hops contains phytoestrogens that may exert oestrogenic agonist or antagonist activities. The effects on hormone-sensitive conditions, such as breast cancer, uterine cancer, cervical cancer, prostate cancer and endometriosis, are unknown. Caution is also advised with concomitant use alongside hormone replacement therapies.
• Zizyphus may have sedative effects. Caution is advised with patients taking CNS depressants.
• Rehmannia and zizyphus have been shown to exert hypoglycaemic activity in animal studies. Thus, caution is advised in patients using antidiabetic medications.
• Shatavari is thought to have diuretic properties that may affect the excretion and serum levels of certain medications including lithium.
• Sage is contraindicated in patients who experience seizures.
• Orally, lavender may cause gastrointestinal upset, constipation, headache and/or increased appetite.
• Theoretically, concomitant use of lavender with antihypertensive, CNS depressant and sedative medications may cause an additive effect.
• Do not exceed a daily intake of 200mg of vitamin C in patients with haemochromatosis.